Regeneron Pharmaceuticals
REGN
$835.75
Share price
1.81%
Change (1 day)
11.81%
Change (1 year)
Categories
Earnings for Regeneron Pharmaceuticals (REGN)
Earnings in 2023 (TTM): $4.37 B
According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are $4.37 B. In 2022 the company made an earning of $4.85 B a decrease over its 2021 earnings that were of $9.32 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Regeneron Pharmaceuticals from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $4.37 B | -9.93% |
| 2022 | $4.85 B | -47.9% |
| 2021 | $9.32 B | 144.75% |
| 2020 | $3.81 B | 56.86% |
| 2019 | $2.42 B | -4.87% |
| 2018 | $2.55 B | 22.85% |
| 2017 | $2.07 B | 56.3% |
| 2016 | $1.32 B | 8.55% |
| 2015 | $1.22 B | 57.92% |
| 2014 | $0.77 B | 8.75% |
| 2013 | $0.71 B | 72.13% |
| 2012 | $0.41 B | -285.93% |
| 2011 | -$0.23 B | 121.3% |
| 2010 | -$0.11 B | 30.6% |
| 2009 | -$77.13 M | -9.88% |
| 2008 | -$85.59 M | -25.23% |
| 2007 | -$0.12 B | 6.32% |
| 2006 | -$0.11 B | -186.52% |
| 2005 | $0.12 B | 2103.7% |
| 2004 | $5.64 M | -105.75% |
| 2003 | -$98.16 M | -19.52% |
| 2002 | -$0.13 B | 47.09% |
| 2001 | -$82.92 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $24.43 B | 458.38% | 🇺🇸 USA |
 Novartis NVS | $8.80 B | 101.12% | 🇨🇭 Switzerland |
 Amgen AMGN | $8.75 B | 99.96% | 🇺🇸 USA |
 Sanofi SNY | $10.77 B | 146.25% | 🇫🇷 France |
 Biogen BIIB | $1.60 B | -63.23% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.39 B | -108.75% | 🇺🇸 USA |